News | April 11, 2026
Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
The reports will now be shared with relevant ministries and departments as a guidance framework
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
Subscribe To Our Newsletter & Stay Updated
